The Boston-based health system’s board of directors named Anne Klibanski, MD, interim chief executive on Feb. 18. Dr. Klibanski has served as Partners’ chief academic officer since 2012 and serves as the chief of neuroendocrine at Boston-based Massachusetts General Hospital.
“Anne is one of our most experienced senior leaders as well as a distinguished clinician, researcher and teacher. She has broad responsibility for many of our key missions and is a proven leader and manager of complex efforts with extensive experience overseeing large clinical and executive teams, crafting a systemwide approach to future state radiology, pathology and anesthesiology structure and investments. Anne will work closely with hospital presidents, clinicians, researchers and administrative leadership to guide important systemwide initiatives such as Partners 2.0,” Scott Sperling, chair of the Partners board of directors, said in a news release.
Dr. Klibanski received her bachelor’s degree in literature from Barnard College and her MD degree from the NYU School of Medicine, both in New York City.
Partners officials said the search for a permanent CEO will take up to one year.
More articles on executive moves:
Geisinger executive to become CMMI senior advisor and medical officer: 4 takeaways
Providence St. Joseph Health names chief people officer: 3 takeaways
Logan Regional Medical Center selects permanent CEO: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
